Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. Multiplex COVID Testing Kits
  6. 21200319

Roche Diagnostics cobas™ Liat SARS-CoV-2, Influenza A/B and RSV RT-PCR Assay Kit

Catalog No. 21200319 Shop All Roche Diagnostics Products
Change view
Click to view available options
Quantity:
1
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
21-200-319 1
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.
Catalog No. 21-200-319 Supplier Roche Diagnostics Supplier No. 09731261190
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy
Order eligibility is based upon executed contractual agreement.

Description

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV nucleic acid test for use on the cobas Liat System is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, Influenza B and RSV in nasopharyngeal or anterior nasal swab specimens.

The cobas™ liat SARS-CoV-2, Influenza A/B and RSV Nucleic acid test for use on the cobas™ Liat™ System is an automated rapid multiplex real-time, reverse transcriptase polymerase chain reaction (RT-PCR) test intended for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A, and influenza B virus, and respiratory syncytial virus nucleic acid in nasopharyngeal swab (NPS) and anterior nasal swab (ANS) specimens from individuals with signs and symptoms of respiratory tract infection. This test has no age restrictions

TRUSTED_SUSTAINABILITY

Specifications

Content And Storage 3 sets of positive and negative controls per kit
Control Sets integrated sample processing control, positive and negative controls
CPT Code 87637 (for assay)
CE Marker Yes
Clia Complexity Waived
Detectable Analytes SARS-CoV-2, Influenza A and B, Rubella Virus Antibodies
Detection Method RT-PCR
DoA Calibrators No
Format Kit
Sample Type For assay: nasaopharyngeal or anterior nasal
Sensitivity For assay: Influenza A, B, RSV = 100% positive agreement; SARS-CoV-2=96.7% positive agreement
Type Control
Disposable Single-use
For Use With (Application) Detection of SARS-CoV-2, Influenza A/B, and RSV
For Use With (Equipment) Used with the cobas™ liat analyzer to validate lots or run control tests
Product Line cobas
Quantity 1
Specificity For assay: SARS-CoV-2=96.7% negative agreement; Influenza A = 98.1% negative agreement; Influenza B = 97.7% negative agreement; RSV = 97.2% negative agreement
Analysis Time 20 min.
Dimensions (L x W x H) 6.1 x 10 x 1.4 in.
Weight (English) 0.1 lb.
Form Ready-to-Use (RTU)
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.